UOTTAIMCU
ONC

University of Texas/Texas AM Investment Management Co (UTIMCO)’s BeOne Medicines Ltd ONC Stock Holding History

University of Texas/Texas AM Investment Management Co (UTIMCO)’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,715
Closed -$3.29M – 44
2020
Q4 		$3.29M Buy
+12,715
New +$3.5M 3.56% 5

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

University of Texas/Texas AM Investment Management Co (UTIMCO)'s ONC Position: Q1 2021 in Review

University of Texas/Texas AM Investment Management Co (UTIMCO) sold out of BeOne Medicines Ltd (ONC) in Q1 2021, closing a stake of 12,715 shares — an estimated $3.29M sold.

University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in ONC in Q4 2020 and held it in 1 quarter. The position peaked at $3.29M in Q4 2020. 252 funds tracked by Wall St. Rank hold ONC as of Q1 2021.

  • University of Texas/Texas AM Investment Management Co (UTIMCO) reported no remaining BeOne Medicines Ltd position as of Q1 2021 after selling out during the quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) sold 12,715 BeOne Medicines Ltd shares in Q1 2021, an estimated $3.29M.
  • University of Texas/Texas AM Investment Management Co (UTIMCO) first reported a position in BeOne Medicines Ltd in Q4 2020 and held it in 1 quarter.
  • University of Texas/Texas AM Investment Management Co (UTIMCO)'s BeOne Medicines Ltd position peaked at $3.29M in Q4 2020.
  • 252 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2021.

Based on University of Texas/Texas AM Investment Management Co (UTIMCO)'s 13F filing for Q1 2021, filed 7 May 2021.